Phase II trial of bevacizumab and lenalidomide with docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Bamidele Adesunloye, Xuan Huang, Yangmin M. Ning, Ravi A. Madan, James L. Gulley, Melony Beatson, Paul Gustav Kluetz, David Adelberg, Philip M. Arlen, Howard L. Parnes, Marcia Mulquin, Seth M. Steinberg, John Joseph Wright, Jane B. Trepel, Nancy Ann Dawson, Clara Chen, Andrea Borghese Apolo, William Douglas Figg, William L. Dahut
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2584952455